Prevalence and medical management of erectile dysfunction in Asia

Asian Journal of Andrology

Volumn 13, Issue 4, 2011, Pages 543-549

  Park, Kwangsung ^a   Hwang, Eu Chang ^a   Kim, Sun Ouck ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Asia; erectile dysfunction; phosphodiesterase inhibitors; prevalence

Indexed keywords

MIRODENAFIL; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL; TADALAFIL; UDENAFIL; VARDENAFIL;

ASIA; BACKACHE; COLOR VISION DEFECT; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ERECTILE DYSFUNCTION; EYE DISEASE; FLUSHING; HEADACHE; HUMAN; LIFE SATISFACTION; MALE; MYALGIA; NAUSEA; NOSE CONGESTION; PREVALENCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHINITIS; SEXUAL BEHAVIOR; SIDE EFFECT; SYSTEMATIC REVIEW; TOOTH PAIN;

ADULT; AGED; ASIA; CARBOLINES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DRUG TOXICITY; ERECTILE DYSFUNCTION; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PREVALENCE; PURINES; PYRIMIDINES; PYRIMIDINONES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SULFONAMIDES; SULFONES; TRIAZINES;

EID: 79960041136     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2010.131     Document Type: Review

References (50)

1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83-90.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61. (Pubitemid 24046934)
3. Nehra A, Kulaksizoglu H. Global perspectives and controversies in the epidemiology of male erectile dysfunction. Curr Opin Urol 2002; 12: 493-6. (Pubitemid 35387443)
4. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17: 39-57. (Pubitemid 40299993)
5. Maas R, Schwedhelm E, Albsmeier J, Boger RH. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc Med 2002; 7: 213-25. (Pubitemid 36104323)
6. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328-38. (Pubitemid 30211093)
7. Tan HM, Marumo K, Yang DY, Hwang TI, Ong ML. Sex among Asian men and women: the Global Better Sex Survey in Asia. Int J Urol 2009; 16: 507-14.
8. Cheng JY, Ng EM, Chen RY, Ko JS. Prevalence of erectile dysfunction in Asian populations: a meta-analysis. Int J Impot Res 2007; 19: 229-44. (Pubitemid 46701450)
9. Bai Q, Xu QQ, Jiang H, Zhang WL, Wang XH et al. Prevalence and risk factors of erectile dysfunction in three cities of China: a community-based study. Asian J Androl 2004; 6: 343-8. (Pubitemid 39654602)
10. Lau JT, Wang Q, Cheng Y, Yang X. Prevalence and risk factors of sexual dysfunction among younger married men in a rural area in China. Urology 2005; 66: 616-22. (Pubitemid 41242334)
11. Tan HM, Low WY, Ng CJ, Chen KK, SugitaMet al. Prevalence and correlates of erectile dysfunction (ED) and treatment seeking for ED in Asian men: the Asian Mens Attitudes to Life Events and Sexuality (MALES) study. J Sex Med 2007; 4: 1582-92. (Pubitemid 47616848)
12. Nicolosi A, Glasser DB, Kim SC, Marumo K, Laumann EO. Sexual behaviour and dysfunction and help-seeking patterns in adults aged 40-80 years in the urban population of Asian countries. BJU Int 2005; 95: 609-14. (Pubitemid 40311482)
13. Wong SY, Leung JC, Woo J. Sexual activity, erectile dysfunction and their correlates among 1,566 older Chinese men in Southern China. J Sex Med 2009; 6: 74-80.
14. Ng EM, Cheng JY. Prevalence and biopsychosocial correlates of erectile dysfunction in Hong Kong: a population-based study. Urology 2007; 70: 131-6. (Pubitemid 47081093)
15. Li MK, Garcia LA, Rosen R. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries. BJU Int 2005; 96: 1339-54. (Pubitemid 41743935)
16. Marumo K, Nakashima J, MuraiM. Age-related prevalence of erectile dysfunction in Japan: assessment by the International Index of Erectile Function. Int J Urol 2001; 8: 53-9. (Pubitemid 32245343)
17. Sasayama S, Ishii N, Ishikura F, Kamijima G, Ogawa S et al. Mens health study: current status of erectile dysfunction of 6,112 ambulatory patients at general practitioners offices in Japan. J Cardiol 2003; 42: 57-65. Japanese. (Pubitemid 40756090)
18. Nicolosi A, Moreira ED Jr, Shirai M, Bin Mohd Tambi MI, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003; 61: 201-6. (Pubitemid 36151741)
19. Ahn TY, Park JK, Lee SW, Hong JH, Park NC et al. Prevalence and risk factors for erectile dysfunction in Korean men: results of an epidemiological study. J Sex Med 2007; 4: 1269-76. (Pubitemid 47337671)
20. Cho BL, Kim YS, Choi YS, Hong MH, Seo HG et al. Prevalence and risk factors for erectile dysfunction in primary care: results of a Korean study. Int J Impot Res 2003; 15: 323-8. (Pubitemid 37376936)
21. Moreira ED Jr, Kim SC, Glasser D, Gingell C. Sexual activity, prevalence of sexual problems, and associated help-seeking patterns in men and women aged 40-80 years in Korea: data from the Global Study of Sexual Attitudes and Behaviors (GSSAB). J Sex Med 2006; 3: 201-11.
22. Khoo EM, Tan HM, Low WY. Erectile dysfunction and comorbidities in aging men: an urban cross-sectional study in Malaysia. J Sex Med 2008; 5: 2925-34.
23. Quek KF, Sallam AA, Ng CH, Chua CB. Prevalence of sexual problems and its association with social, psychological and physical factors among men in a Malaysian population: a cross-sectional study. J Sex Med 2008; 5: 70-6.
24. Tan JK, Hong CY, Png DJ, Liew LC, Wong ML. Erectile dysfunction in Singapore: prevalence and its associated factors-a population-based study. Singapore Med J 2003; 44: 20-6. (Pubitemid 36432979)
25. Hwang TI, Tsai TF, Lin YC, Chiang HS, Chang LS. A survey of erectile dysfunction in Taiwan: use of the Erection Hardness Score and Quality of Erection Questionnaire. J Sex Med 2010; 7: 2817-24.
26. Wu CJ, Hsieh JT, Lin JS, Hwang TI, Jiann BP et al. Comparison of prevalence between self-reported erectile dysfunction and erectile dysfunction as defined by five-item International Index of Erectile Function in Taiwanese men older than 40 years. Urology 2007; 69: 743-7. (Pubitemid 46574913)
27. Chen KK, Chiang HS, Jiann BP, Lin JS, Liu WJ et al. Prevalence of erectile dysfunction and impacts on sexual activity and self-reported intercourse satisfaction in men older than 40 years in Taiwan. Int J Impot Res 2004; 16: 249-55. (Pubitemid 38858958)
28. Permpongkosol S, Kongkakand A, Ratana-Olarn K, Tantiwong A, Tantiwongse K. Increased prevalence of erectile dysfunction (ED): results of the second epidemiological study on sexual activity and prevalence of ED in Thai males. Aging Male 2008; 11: 128-33.
29. Moreira ED Jr, Brock G, Glasser DB, Nicolosi A, Laumann EO et al. Help-seeking behaviour for sexual problems: the global study of sexual attitudes and behaviors. Int J Clin Pract 2005; 59: 6-16. (Pubitemid 40260106)
30. Tsertsvadze A, Fink HA, Yazdi F, MacDonald R, Bella AJ et al. Oral phosphodiesterase-inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med 2009; 151: 650-61.
31. Tan HM, Moh CL, Mendoza JB, Gana T, Albano GJ et al. Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction. The Assess-1 Study Group. Urology 2000; 56: 635-40.
32. Kongkanand A, Ratana-Olarn K, Ruangdilokrat S, Tantiwong A. The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study. J Med Assoc Thai 2003; 86: 195-205. (Pubitemid 36781940)
33. Chen KK, Hsieh JT, Huang ST, Jiaan DB, Lin JS et al. ASSESS-3: a randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan. Int J Impot Res 2001; 13: 221-9. (Pubitemid 32743603)
34. Choi HK, Ahn TY, Kim JJ, Kim SC, Paick JS et al. A double-blind, randomisedplacebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in Korea. Int J Impot Res 2003; 15: 80-6. (Pubitemid 36604993)
35. Tan HM, Chin CM, Chua CB, Gatchalian E, Kongkanand A et al. Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction. Asian J Androl 2008; 10: 495-502. (Pubitemid 351584126)
36. Chen KK, Paick JS, Ishii N. The efficacy and safety of vardenafil in East Asianmen with erectile dysfunction. J Sex Med 2007; 4: 753-61. (Pubitemid 46779312)
37. Yip WC, Chiang HS, Mendoza JB, Tan HM, Li MK et al. Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study. Asian J Androl 2006; 8: 685-92. (Pubitemid 44869616)
38. Guo YL, Zhu JC, Pan TM, Ding Q, Wang YX et al. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men. Int J Urol 2006; 13: 721-7. (Pubitemid 43926762)
39. Chen KK, Jiann BP, Lin JS, Lee SS, Huang ST et al. Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study. J Sex Med 2004; 1: 201-8. (Pubitemid 40424654)
40. Guo YL, Viswanathan VP, Chiang HS, Choi HK, Yip AW et al. Efficacy and safety of tadalafil taken as needed for the treatment of erectile dysfunction in Asian men: results of an integrated analysis. Asian J Androl 2009; 11: 423-33.
41. Paick JS, Kim SW, Yang DY, Kim JJ, LeeSWet al. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. J Sex Med 2008; 5: 946-53. (Pubitemid 351472204)
42. Park HJ, Park JK, Park K, Min K, Park NC. Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial. J Sex Med 2010; 7: 2209-16.
43. Paick JS, Choi HK, Kim SC, Ahn TY, Kim JJ et al. Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial. Asian J Androl 2008; 10: 791-8.
44. Paick JS, Ahn TY, Choi HK, Chung WS, Kim JJ et al. Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction. J Sex Med 2008; 5: 2672-80.
45. Porst H, Rosen R, Padma-Nathan H, Goldstein I, Giuliano F et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res 2001; 13: 192-9. (Pubitemid 32743600)
46. Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M et al. Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, doubleblind, 26-week placebo-controlled pivotal trial. Urology 2003; 61: 8-14. (Pubitemid 36349124)
47. Choi HK, Kim JJ, Kim SC, Suh J, Park YK et al. A randomised, double-blind, parallel, placebo-controlled study of the efficacy and safety of tadalafil administered ondemand to men with rectile dysfunction in Korea. Korean J Urol 2006; 47: 852-58. (Pubitemid 44741009)
48. Doh H, Shin CY, Son M, Ko JI, Yoo M et al. Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159. Arch Pharm Res 2002; 25: 873-8. (Pubitemid 43066579)
49. Salem EA, Kendirci M, Hellstrom WJ. Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction. Curr Opin Investig Drugs 2006; 7: 661-9. (Pubitemid 44018351)
50. Lee J, Yoo HH, Rhim KJ, Sohn DR, Kim DH. Metabolism and excretion of 5- ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl- 3,5 dihydropyrrolo [3,2-d]-pyrimidin-4-one (SK3530) in rats. Rapid Commun Mass Spectrom 2007; 21: 1139-49.